VENTANA pan-TRK (EPR17341) Assay

The VENTANA pan-TRK (EPR17341) Assay:

  • The first assay of its type to detect tropomyosin receptor kinase (TRK) with anticipated use across multiple solid tumour types.
  • The assay is expected to provide improved data on the prevalence of TRK proteins in tumour tissue studies.
  • The significance of TRK fusion proteins is currently being investigated in various cancer indications

This product is intended for in vitro diagnostic (IVD)

    Posted in: